PRQR

1.0400.95%
DA

Daniel Anton de Boer

Founder, CEO & Executive Director

Mr. Daniel Anton de Boer has been the Chief Executive Officer at ProQR Therapeutics N.V. since February 21, 2012 and serves as its Executive Director since May 2024 and served as its Member of Management Board. He serves as Member of Strategic Advisory Board at Hybridize Therapeutics B.V. He founded ProQR Therapeutics N.V. in February 2012. He was also a co-founder and strategic advisor of Amylon Therapeutics and Wings Therapeutics. In 2018 he was named "Emerging Entrepreneur of the Year" by EY. In 2019 he was selected for the Young Global Leaders program at the World Economic forum. He is strategic advisor at Frame Therapeutics, Meatable, Algramo and a member of the advisory board at the Termeer Foundation. He is a serial entrepreneur in IT, he founded and led several tech companies through phases of growth, initiating development and launch of several IT related products in several European countries. He served as a founder and Chief Executive Officer of RNA Systems from 2009 to 2011. From 2007 to 2008, he was Founder and Chief Executive Officer of PC Basic and from 2005 to 2011, he served as a Founder and Chief Executive Officer of Running IT.

Positions